NCT04765761

Brief Summary

ProSeal laryngeal mask airway (PLMA) has become an effective alternative to tracheal tube for gaining airway access and for the institution and maintenance of positive pressure ventilation (PPV) in patients undergoing short-to-moderate duration (20-60 minutes) surgery under GA. The PLMA is the more preferred supra-glottic airway access device for advantages therein over the other SGA's, including having an option of dedicated introducer-tool (ease of placement), availability of esophageal opening (allows regurgitated fluid to bypass the airway), and reinforced main body tube (prevents luminal compression). Additionally, as compared to other supra-glottic airway devices, the PLMA device has been found to be more consistent in providing PPV to patients' lungs during GA. However, not uncommonly, PLMA itself is not consistent in maintaining trouble-free PPV owing to the vulnerability to position change, especially secondary to the rhythmic movement posited by back pressure during PPV. This movement vulnerability induced by PPV may be because of the size/shape of PLMA cuff that does fit upon placement but gets vulnerable to undue movement during PPV. We hypothesize that keeping the introducer-tool in position after insertion of PLMA result in greater stabilization of PLMA in position by minimizing the movement that occurs due to back-pressure effect on the cuff during positive pressure ventilation. This randomized study intends to evaluate whether keeping the introducer-tool in position (after PLMA insertion) accords greater positional stabilization to the PLMA and thereby offers greater efficacy for achieving adequate pressure control ventilation in paralyzed anesthetized adults undergoing elective surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 17, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 21, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

March 3, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 16, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2022

Completed
Last Updated

August 15, 2023

Status Verified

August 1, 2023

Enrollment Period

1 year

First QC Date

February 17, 2021

Last Update Submit

August 11, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oropharyngeal Seal pressure of the PLMA

    Oropharyngeal seal pressure (in cmH2O) will be measured by closing the expiratory valve of the anaesthetic circle system at a fixed gas flow rate of 3L/min, and noting the equilibrated upper airway pressure

    From time of insertion of PLMA till 120-minutes intraoperatively

Secondary Outcomes (6)

  • Efficiency of positive pressure ventilation (PPV)

    From time of insertion of PLMA till 120-minutes intraoperatively

  • Postoperative sore throat

    From end of surgery till 24 hours postoperatively

  • Postoperative cough

    From end of surgery till 24 hours postoperatively

  • Postoperative difficulty in swallowing

    From end of surgery till 24 hours postoperatively

  • Postoperative difficulty in speaking

    From end of surgery till 24 hours postoperatively

  • +1 more secondary outcomes

Study Arms (2)

PLMA with Introducer'

ACTIVE COMPARATOR

PLMA placed in position with the help of the introducer-tool and then the introducer-tool retained in place throughout the institution and duration of positive pressure ventilation.

Device: PLMA with introducer

PLMA without Introducer

ACTIVE COMPARATOR

PLMA placed in position with the help of the introducer-tool and then the introducer-tool removed before institution of positive pressure ventilation.

Device: PLMA without introducer

Interventions

The pro-seal laryngeal mask airway (PLMA) will be inserted along with introducer tool which will be kept in-situ throughout the duration of positive pressure ventilation

PLMA with Introducer'

The pro-seal laryngeal mask airway (PLMA) will be inserted along with introducer tool which will be removed after insertion and patient will be ventilated using PLMA without the introducer in-situ throughout the duration of positive pressure ventilation

PLMA without Introducer

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20 - 60 years.
  • ASA physical status I and II.

You may not qualify if:

  • Patients having complaints of acid-peptic disease, chronic constipation, feeling of stomach fullness after meal.
  • Previous gastrointestinal surgery
  • History of hiatus hernia
  • Known case of substance abuse or chronic alcoholism
  • Psychiatric illness
  • Pregnant patients
  • Anatomical defects of the mandible.
  • Dental problems (Missing teeth, loose teeth)
  • Surgery requiring Trendelenburg position.
  • Surgery requiring position change during procedure
  • Morbid obesity with OSAS.
  • Failure to obtain consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nitin Sethi

New Delhi, National Capital Territory of Delhi, 110060, India

Location

MeSH Terms

Conditions

Airway Remodeling

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Rakesh Saxena, MBBS, MD

    Sir Ganga Ram Hospital, New Delhi, INDIA

    STUDY CHAIR
  • Amitabh Dutta, MD, PGDHR

    Sir Ganga Ram Hospital, New Delhi, INDIA

    PRINCIPAL INVESTIGATOR
  • Abishek SS

    Sir Ganga Ram Hospital, New Delhi, INDIA

    PRINCIPAL INVESTIGATOR
  • Manish Kohli, DA, DNB

    Sir Ganga Ram Hospital, New Delhi, INDIA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient will be blinded to the study intervention as designated by the randomized group he/she would be allocated to. The investigator however will not be blinded to the group allocation.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patients will be randomly allocated into 2-groups. Group-1 will be the 'PLMA with Introducer' group and group-2 will be the 'PLMA without Introducer' group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant

Study Record Dates

First Submitted

February 17, 2021

First Posted

February 21, 2021

Study Start

March 3, 2021

Primary Completion

March 16, 2022

Study Completion

March 16, 2022

Last Updated

August 15, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations